About MorphoSys
MorphoSys is a company based in Planegg (Germany) founded in 1992 by Andreas Pluckthun was acquired by Novartis in February 2024.. The company has 732 employees as of December 31, 2021. MorphoSys has completed 4 acquisitions, including Biogenesis, Constellation Pharma and Lanthio Pharma. MorphoSys operates in a competitive market with competitors including Merck, AbbVie, Lilly, BeiGene and Roche, among others.
- Headquarter Planegg, Germany
- Employees 732 as on 31 Dec, 2021
- Founders Andreas Pluckthun
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
$-126.36 M-48as on Dec 31, 2020
-
EBITDA
$-124.85 M-45as on Dec 31, 2020
-
Latest Funding Round
$383.84 M (USD), Post-IPO
Oct 13, 2020
-
Investors
Novartis
& 1 more
-
Employee Count
732
as on Dec 31, 2021
-
Investments & Acquisitions
Biogenesis
& 3 more
-
Acquired by
Novartis
(Feb 06, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
194 people
Software Development Team
81 people
Senior Team
64 people
Sales and Marketing
49 people
Data Analysis and Operations Team
28 people
Human Resources and Administration
22 people
Product Management Team
20 people
Operations Team
19 people
Unlock access to complete
Funding Insights of MorphoSys
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $383.8M
-
First Round
First Round
(19 Sep 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2020 | Amount | Post-IPO - MorphoSys | Valuation |
investors |
|
| Jan, 2020 | Amount | Post-IPO - MorphoSys | Valuation |
investors |
|
| Nov, 2016 | Amount | Post-IPO - MorphoSys | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MorphoSys
MorphoSys has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Novartis and Incyte. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Small molecules are developed for cancer and skin disease treatments.
|
Founded Year | Domain | Location | |
|
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MorphoSys
MorphoSys has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Biogenesis, Constellation Pharma and Lanthio Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Speciality company developing and commercializing therapeutic peptide drugs against difficult to target receptors
|
2010 | ||||
|
Developer of drugs in the field of epigenetics
|
2008 | ||||
|
Technology for the construction of protein libraries
|
2001 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - MorphoSys
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Morphosys Comparisons
Competitors of MorphoSys
MorphoSys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, AbbVie, Lilly, BeiGene and Roche, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| domain | founded_year | HQ Location |
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Morphosys
Frequently Asked Questions about MorphoSys
When was MorphoSys founded?
MorphoSys was founded in 1992 and raised its 1st funding round 21 years after it was founded.
Where is MorphoSys located?
MorphoSys is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.
Who is the current CEO of MorphoSys?
Jean-Paul Kress is the current CEO of MorphoSys.
How many employees does MorphoSys have?
As of Dec 31, 2021, the latest employee count at MorphoSys is 732.
What does MorphoSys do?
Founded in 1992 and based in Planegg, Germany, MorphoSys operates as an integrated biopharma company focused on the discovery, development, and commercialization of therapeutic antibodies. Targets include cancer, Alzheimers disease, infectious diseases, cardiovascular dysfunction, and inflammation. Key technologies encompass HuCAL and Ylanthia libraries for generating human antibodies. The lead product candidate, MOR208, addresses diffuse large B-cell lymphoma.
Who are the top competitors of MorphoSys?
MorphoSys's top competitors include Merck, Moderna and Roivant Sciences.
How many acquisitions has MorphoSys made?
MorphoSys has made 4 acquisitions, including Biogenesis, Constellation Pharma, and Lanthio Pharma.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.